BRIEF-Biofrontera AG says pre-NDA meeting scheduled with FDA for approval of Ameluz and BF-RhodoLED

Thu Aug 21, 2014 8:35am EDT

Related Topics

Aug 21 (Reuters) - Biofrontera AG : * Says pre-NDA meeting scheduled with FDA for the approval of Ameluz and BF-RhodoLED * Says has scheduled the pre-NDA (new drug application) meeting for 8 October

2014 * Source text for Eikon * Further company coverage

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.